Clinical Trial Update: triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating triPle oral therapy including bempedoic acid for early lipid management in patients with acute coronary syndrome; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Hyperlipidemia

Drugs mentioned

• Nexletol (bempedoic acid)

Snippet

Sponsor: Heart Care Foundation | Conditions: Acute Coronary Syndromes, Secondary Prevention | Phase 3 | Status: NOT_YET_RECRUITING